Worsening on DSS is not a useful entry criterion for multiple sclerosis clinical trials to prevent progression

被引：0
|
作者：
Myers, LW
Leake, BD
Ellison, GW
机构：
来源：
ANNALS OF NEUROLOGY | 1996年 / 40卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：T240 / T240
页数：1
相关论文
共 50 条
  • [1] A USEFUL ENTRY CRITERION FOR MULTIPLE-SCLEROSIS CLINICAL-TRIALS TO PREVENT PROGRESSION
    MYERS, LW
    LEAKE, BD
    ELLISON, GW
    ANNALS OF NEUROLOGY, 1995, 38 (02) : 339 - 339
  • [2] PROGRESSION PHASE OF MULTIPLE-SCLEROSIS NOT A USEFUL ENTRY CRITERION FOR THERAPEUTIC TRIALS
    MYERS, LW
    ELLISON, GW
    LEAKE, BD
    ANNALS OF NEUROLOGY, 1993, 34 (02) : 312 - 312
  • [3] Composite confirmed disability worsening is a useful clinical trial endpoint for multiple sclerosis focusing on a disability progression
    Kappos, Ludwig
    Yiu, Sean
    Cutter, Gary
    Coetzee, Timothy
    Bonati, Ulrike
    Yuen, Steven
    Dahlke, Frank
    Lublin, Fred
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 338 - 339
  • [4] Recurrent disability progression endpoints in multiple sclerosis clinical trials
    Buehler, Alexandra
    Wolbers, Marcel
    Model, Fabian
    Wang, Qing
    Belachew, Shibeshih
    Manfrini, Marianna
    Lorscheider, Johannes
    Kappos, Ludwig
    Beyersmann, Jan
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (01) : 130 - 139
  • [5] Prognostic models for predicting clinical disease progression, worsening and activity in people with multiple sclerosis
    Reeve, Kelly
    On, Begum Irmak
    Havla, Joachim
    Burns, Jacob
    Gosteli-Peter, Martina A.
    Alabsawi, Albraa
    Alayash, Zoheir
    Gotschi, Andrea
    Seibold, Heidi
    Mansmann, Ulrich
    Held, Ulrike
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (09):
  • [6] Impact of informative censoring on the treatment effect estimate of disability worsening in multiple sclerosis clinical trials
    Riester, Katherine
    Kappos, Ludwig
    Selmaj, Krzysztof
    Lindborg, Stacy
    Lipkovich, Ilya
    Elkins, Jacob
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
  • [7] Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful
    Avolio, Carlo
    Centonze, Diego
    NEUROLOGY AND THERAPY, 2022, 11 (01) : 1 - 8
  • [8] Pivotal Trials in Multiple Sclerosis: Similarities Prove Not to Be Useful
    Carlo Avolio
    Diego Centonze
    Neurology and Therapy, 2022, 11 : 1 - 8
  • [9] Validity of brain MRI as the primary outcome criterion in multiple sclerosis phase II clinical trials
    Liedtke, W
    Limmroth, V
    ANNALS OF NEUROLOGY, 1996, 39 (02) : 276 - 276
  • [10] Clinical trials in multiple sclerosis: milestones
    Zhang, Yinan
    Salter, Amber
    Cutter, Gary
    Stuve, Olaf
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
12345